Paclitaxel Polymeric Micelle | Nanoparticle Drug Delivery System for Anticancer Research

Sale

Paclitaxel Polymeric Micelle | Nanoparticle Drug Delivery System for Anticancer Research

Original price was: $3.00.Current price is: $2.00.

Paclitaxel Polymeric Micelle is a nanocarrier-based drug delivery system designed for preclinical oncology research. It enhances paclitaxel solubility, bioavailability, and tumor targeting efficiency for advanced pharmacological and mechanistic studies.

EMI starting from $0.00/month - View Plans

Description

Product Description

Paclitaxel Polymeric Micelle represents an innovative nanoformulation approach to enhance the pharmacokinetic and biopharmaceutical properties of paclitaxel, one of the most widely studied microtubule-stabilizing anticancer compounds. Due to its poor aqueous solubility and systemic toxicity when administered as a conventional formulation, researchers have turned to polymeric micelles to improve its solubility, circulation stability, and targeted delivery efficiency.

This advanced nanocarrier system encapsulates paclitaxel within amphiphilic copolymers—typically PEG-PLA, PEG-PCL, or other biodegradable polymers—to form nanoscale micellar structures. These micelles possess a hydrophobic core that solubilizes paclitaxel and a hydrophilic shell that stabilizes dispersion in aqueous environments. The resulting system provides extended circulation time, passive tumor targeting via the enhanced permeability and retention (EPR) effect, and reduced systemic toxicity.

In oncology research, Paclitaxel Polymeric Micelle is extensively used to study nanoparticle-based pharmacokinetics, cellular uptake, intracellular trafficking, and tumor accumulation. It offers a reliable model for exploring controlled drug release mechanisms, polymer-drug compatibility, and biodistribution in both in vitro and in vivo studies.

Experimental investigations often demonstrate that this formulation provides superior tumor suppression compared with free paclitaxel due to sustained drug exposure, improved tumor tissue penetration, and enhanced cellular retention. The nanoformulation also reduces the need for toxic solubilizers like Cremophor EL, enabling researchers to examine drug delivery efficacy without confounding solvent effects.

Paclitaxel Polymeric Micelle’s well-defined particle size distribution (typically 20–100 nm) ensures consistent pharmacological behavior in experimental models. Its high purity (≥99%) guarantees reproducibility across research applications, from mechanistic cancer biology to formulation optimization and nanomedicine development.


Product Specifications

ItemDetails
Product NamePaclitaxel Polymeric Micelle
CAS NumberN/A
SynonymsPolymeric Paclitaxel Micelle; PTX Micelle; Nano Paclitaxel
Molecular FormulaC47H51NO14 (Paclitaxel core)
Molecular Weight853.91 g/mol
Purity≥99%
AppearanceWhite to off-white lyophilized powder
SolubilitySoluble in water and ethanol; forms stable micellar solution
Storage Temperature2–8 °C, protected from light
CategoryPolymeric nanoparticle formulation
ApplicationsOncology research, targeted drug delivery, pharmacokinetic and biodistribution studies
FormulationPEG-based micelle incorporating paclitaxel
StabilityStable under recommended laboratory storage conditions
Shelf Life24 months
Supplier TypeResearch chemical supplier
Intended UseFor laboratory research use only
Packaging Options10 mg – 1 kg sealed powder in moisture-proof containers
Delivery ModeCold-chain logistics with tracking and insurance

Mechanism of Action

Paclitaxel Polymeric Micelle works through two complementary mechanisms:

  1. Microtubule Stabilization (Pharmacodynamic Mechanism)

  2. Nanocarrier-Mediated Drug Delivery (Pharmacokinetic Mechanism)

1. Microtubule Stabilization:
Paclitaxel stabilizes microtubules by binding to β-tubulin subunits, preventing depolymerization and disrupting normal mitotic spindle formation. This leads to mitotic arrest at the G2/M phase and programmed cell death (apoptosis). The polymeric micelle serves as a carrier that ensures controlled release of the active molecule at tumor sites, enabling prolonged cytotoxic exposure.

2. Nanocarrier Drug Delivery:
The polymeric micelle encapsulates paclitaxel in its hydrophobic core, shielding the compound from premature degradation and improving systemic circulation. The hydrophilic corona provides stealth properties, minimizing opsonization and reticuloendothelial clearance. Through passive targeting mechanisms, the nanoparticles accumulate preferentially in tumor tissues exhibiting the EPR effect.

Research Applications:

  • Tumor-targeted delivery: studying enhanced tumor accumulation and controlled release kinetics.

  • Pharmacokinetic studies: evaluating biodistribution, circulation half-life, and metabolic fate.

  • Combination therapy models: investigating co-delivery with other anticancer agents or siRNA molecules.

  • Cellular uptake analysis: using fluorescence or confocal microscopy to visualize endocytosis and cytoplasmic release.

Paclitaxel Polymeric Micelle provides a reproducible nanomedicine research platform for studying targeted delivery, drug release dynamics, and pharmacological modulation in cancer biology.

Paclitaxel Polymeric Micelle
Paclitaxel Polymeric Micelle

Side Effects

While Paclitaxel Polymeric Micelle reduces systemic toxicity compared to conventional formulations, it still exhibits paclitaxel-related cytotoxic effects in preclinical assays:

  • Mitotic arrest and apoptosis: microtubule stabilization leads to cell cycle arrest and activation of caspase cascades.

  • Cytoskeletal disruption: inhibition of cell division and motility in rapidly proliferating cells.

  • Inflammatory responses: mild cytokine induction during nanoparticle uptake.

  • Oxidative stress modulation: mitochondrial activity alteration during prolonged exposure.

  • Endothelial barrier effects: temporary changes in cell permeability under high concentrations.

Laboratory Safety Guidelines:

  • Handle under sterile, ventilated conditions.

  • Use gloves, mask, and protective clothing.

  • Avoid inhalation and direct skin contact.

  • Dispose of waste following institutional nanomaterial safety protocols.

Paclitaxel Polymeric Micelle is for research use only and not for human or veterinary application.


Keywords

Paclitaxel Polymeric Micelle, paclitaxel nanocarrier, polymeric micelle drug delivery, nano paclitaxel formulation, nanoparticle oncology research, controlled release, PEG-PLA micelle, tumor-targeted nanomedicine, anticancer nanoformulation, research chemical supplier.


Shipping Guarantee

All shipments are handled using validated cold-chain logistics systems to maintain micelle stability and prevent degradation. Every order is sealed in moisture-proof packaging with dual-layer insulation and temperature control. Global express couriers with tracking and insurance are employed to ensure timely and secure delivery. Each package includes batch information and Certificate of Analysis (CoA) for verification.


Trade Assurance

We guarantee product authenticity and purity ≥99%, verified through HPLC, DLS, and TEM analysis. Each batch undergoes sterility and particle size validation to ensure reproducibility. Any deviations from specifications are covered by full refund or replacement. Long-term collaboration contracts and bulk-supply traceability are available for research institutes and OEM laboratories.


Payment Support

We provide global, flexible, and secure payment options for international research partners. Accepted methods include PayPal, major credit cards (Visa, MasterCard, American Express), telegraphic transfer (T/T), and digital assets (USDT, Bitcoin, Ethereum). All transactions are protected through SSL encryption and verified gateways. Institutional purchase orders and invoicing are supported for large-scale projects.


Disclaimer

All products are strictly intended for laboratory research use only and not for human or veterinary applications. They are not drugs, medical devices, or diagnostics. Researchers must comply with institutional biosafety and nanomaterial handling protocols. Information is provided solely for scientific and educational reference purposes.

Additional information

Weight1.1 kg
Dimensions18 × 16 × 18 cm

Reviews

There are no reviews yet.

Be the first to review “Paclitaxel Polymeric Micelle | Nanoparticle Drug Delivery System for Anticancer Research”

Your email address will not be published. Required fields are marked *

1. What is Paclitaxel Polymeric Micelle used for?

It is primarily used in oncology research to study nanoparticle-mediated drug delivery, tumor targeting, and pharmacokinetic improvement of paclitaxel.

2. What is the purity of Paclitaxel Polymeric Micelle?

Each batch is ≥99% pure and validated by HPLC and DLS particle analysis.

3. How should Paclitaxel Polymeric Micelle be stored?

Store at 2–8 °C in a sealed container, away from light and moisture.

4. Is Paclitaxel Polymeric Micelle water-soluble?

Yes. It forms stable micellar dispersions in aqueous media suitable for cell and in vivo studies.

5. Can it be used in combination therapy research?

Yes. It can be co-loaded or co-administered with other anticancer agents to study synergistic effects.

6. Is this product available from China peptide or nanoparticle suppliers?

Yes, it is distributed by factory peptide suppliers and nanoparticle formulation manufacturers specializing in research-grade materials.

7. Is OEM or bulk production supported?

Yes, OEM & bulk nanoparticle production services are available for institutional or industrial research.

8. What analytical data is provided?

A full Certificate of Analysis (CoA) including particle size, PDI, zeta potential, and purity is provided.

9. What are common research applications?

Angiogenesis inhibition, tumor pharmacokinetics, cellular uptake, and controlled drug release studies.

10. How long is the shelf life?

Stable for up to 24 months under recommended storage conditions.

11. Does it contain Cremophor EL?

No. The polymeric micelle eliminates toxic surfactants used in traditional formulations.

12. Is it available for bulk purchase from peptide wholesale China suppliers?

Yes, large-scale quantities and OEM services are supported by China-based nanocarrier manufacturers.

13. What makes Paclitaxel Polymeric Micelle a preferred formulation?

Its stability, biocompatibility, and tumor-targeting ability make it ideal for preclinical nanomedicine research.

14. What safety precautions are needed?

Use in biosafety cabinets with personal protective equipment to avoid nanoparticle exposure.

15. Are custom micellar formulations available?

Yes, customized polymer ratios, drug loading capacities, and particle size tuning are available upon request.


EMI Options